Article
The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Oct 2024
Dermawan Josephine K, Abramson David H, Chiang Sarah, Hensley Martee L, Tap William D, Movva Sujana, Maki Robert G, Mandelker Diana, Antonescu Cristina R
Abstract excerpt
PURPOSE: Leiomyosarcomas (LMS) are clinically and molecularly heterogeneous, occurring mostly in sporadic but also syndromic settings. The role of pathogenic germline variants (PGV) as LMS drivers and their impact on outcomes remains uncertain. EXPERIMENTAL DESIGN: We performed a comprehensive clinicopathologic and molecular analysis using a tumor-normal DNA next-generation sequencing assay (Memorial Sloan...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
